All In Biotech

Free tool

FAERS Monitor: Zemplar

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020819 or its brand name (Zemplar, Paricalcitol). Reports on generic versions are filed under their own applications.

Reports

14,054

Serious

12,725

91% of reports

Hospitalization

3,641

Death reported

8,430

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death3,570
  • cardiac disorder622
  • myocardial infarction584
  • sepsis483
  • cardio-respiratory arrest477
  • dyspnoea395
  • cardiac failure348
  • renal failure308
  • pneumonia303
  • nausea302
  • cerebrovascular accident285
  • asthenia277
  • diarrhoea276
  • vomiting272
  • fatigue268

Reports by year received

View as table
YearReports
200428
200571
2006148
2007159
2008335
2009705
2010449
2011499
2012368
20131,819
20142,367
20152,117
20161,826
2017797
2018628
2019515
2020377
2021268
2022246
2023212
202460
202531
202629

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,105 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
cardio-respiratory arrestSignal47717.315.87,221
cardiac disorderSignal62210.09.35,024
cardiac failureSignal3486.55.91,617
sepsisSignal4836.56.02,247
deathSignal3,5706.26.016,246
myocardial infarctionSignal5845.04.61,887
renal failureSignal3083.53.1543
cerebrovascular accidentSignal2852.52.2261
pneumonia3031.41.335
asthenia2771.11.03
dyspnoea3951.00.91
vomiting2720.90.86
diarrhoea2760.60.657
nausea3020.60.5101
fatigue2680.50.5127

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.